Results 41 to 50 of about 1,691,473 (292)
Biomedicines, 2023 Treatment resistant schizophrenia (TRS) is characterized by a lack of, or suboptimal response to, antipsychotic agents. The biological underpinnings of this clinical condition are still scarcely understood.
Felice Iasevoli +8 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Primary cutaneous anaplastic large cell lymphoma (pcALCL) is a rare pediatric CD30‐positive T‐cell lymphoproliferative disorder with an excellent prognosis, but its genomic drivers are poorly defined. We report three children with skin‐limited disease demonstrating striking molecular heterogeneity, including NPM::ALK, NUP214::FRK, and a novel ...
Shoshana Greenberger +7 more
wiley +1 more source
DEPRESSIVE SYMPTOMS IN FIRST EPISODE SCHIZOPHRENIA: A SIX-MONTH FOLLOW-UP STUDY
Psychiatry and Clinical Psychopharmacology, 2021 Objective: In this study we aimed to find the prevalence of depressive symptoms in first-episode schizophrenia, and to determine the relationship between depressive symptoms and positive/negative symptoms of schizophrenia.
Özcan Uzun +3 more
doaj
Perception of burden by caregivers of patients with schizophrenia in relation to symptom profile
Annals of Indian Psychiatry, 2019 Background: Schizophrenia begins early in life causing significant long-lasting impairments. The caregivers face physical, psychological, and economic difficulties in taking care of them.
Bharathi Gunjahalli, P M Chougule
doaj +1 more source
Validation of the Arabic version of the “self-evaluation of negative symptoms” scale (SNS)
BMC Psychiatry, 2020 Background The self-evaluation of negative symptoms scale (SNS) is a new easy-to-use self-administered questionnaire allowing clinicians to understand the clinical and genetic factors affecting the negative symptoms in patients with schizophrenia.
Aline Hajj +7 more
doaj +1 more source
Responsivity of Negative Symptoms to Typical Neuroleptic Drugsin Schizophrenia [PDF]
, 1996 The psychopharmacological management of schizophrenia consists primarily of neuroleptics. These drugs have successfully changed the scenario of psychiatry since the 1950s. They have mainly been used for controlling positive symptoms in schizophrenia, but
Nakane, Yoshibumi +2 more
core
The explanatory role of facets of dispositional mindfulness and negative beliefs about worry in anxiety symptoms [PDF]
, 2020 Dispositional mindfulness (DM) has been linked to a number of mental health outcomes, including anxiety. Metacognitive models of anxiety posit that an individual's negative beliefs about the danger and uncontrollability of their worry predict the ...
Emerson, DLM +3 more
core +1 more source
Psychiatry and Clinical Psychopharmacology, 2021 Objective: Combined antipsychotic treatment is frequently used in clinical practice either to improve the symptom control or to reduce the severity of side effects.
Ersin Hatice Karslioglu +8 more
doaj +1 more source
Roles of attachment, reflective function and emotion regulation in the development of negative symptoms [PDF]
, 2019 In the context of developmental psychopathology and the psychological and social risk factors associated with psychosis and ‘schizophrenia’, this thesis proposes that early attachment interactions underlie the development of reflective function and ...
Thomson, Alice
core
Physical appearance perfectionism explains variance in eating disorder symptoms above general perfectionism [PDF]
, 2015 Physical appearance perfectionism is a domain-specific form of perfectionism comprising two components: hope for perfection and worry about imperfection (Yang & Stoeber, 2012).
Stoeber, Joachim, Yang, Hongfei
core +1 more source